Pfizer Hits New 52-Week Low Amid Ongoing Downward Trend and Weak Financial Metrics

Pfizer has experienced significant activity today, reaching a new 52-week low of Rs. 3742.9. This decline marks a continuation of a downward trend, with the stock falling for two consecutive days and recording a total drop of -5.36% during this period. The stock opened with a gap down of -2.36% and hit an intraday low of Rs. 3742.9, reflecting a decrease of -6.22% at its lowest point.
In terms of performance metrics, Pfizer is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish technical trend. Over the past year, the stock has underperformed significantly, with a return of -11.41%, contrasting sharply with the Sensex's decline of only -1.96%.

Financially, Pfizer's net sales growth has been modest at an annual rate of 0.46%, while operating profit has increased by 4.27% over the last five years. The company's recent quarterly results showed a decline in profit after tax, down -16.6%, and a low debtors turnover ratio of 9.84 times. Despite a high return on equity of 16.4, the stock is considered to have an expensive valuation, trading at a premium compared to its peers.